Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan · Delayed Price · Currency is TWD 51.40
-2.70 (-4.99%)
At close: Jul 9, 2026
Pet Pharm Biotech Market Cap
Pet Pharm Biotech has a market cap or net worth of 2.94 billion as of July 9, 2026. Its market cap has decreased by -1.99% in one year.
Market Cap
2.94B
Enterprise Value
2.55B
Revenue
222.03M
Ranking
n/a
PE Ratio
111.74
Stock Price
51.40
Market Cap Chart
Since July 26, 2024, Pet Pharm Biotech's market cap has increased from 1.39B to 2.94B, an increase of 111.31%. That is a compound annual growth rate of 46.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 2.94B | -17.93% |
| Dec 31, 2025 | 3.58B | 116.51% |
| Dec 31, 2024 | 1.66B | 18.92% |
| Jul 26, 2024 | 1.39B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TLC BioSciences | 35.13B |
| HanchorBio | 20.28B |
| Elixiron Immunotherapeutics (Cayman) Limited | 9.95B |
| Tripartite Therapeutics | 7.54B |
| Uwell Biopharma | 7.23B |
| Intelligene | 6.44B |
| Obigen Pharma | 3.86B |
| BIONET Therapeutics | 2.48B |